Moxifloxacin prophylaxis for chemoembolization or embolization in patients with previous biliary interventions: a pilot study.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 21785063.
- Also identified by DOI 10.2214/AJR.10.6019.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Abscess formation is a common serious adverse event after intraarterial therapy for hepatic malignancy in patients with colonized bile ducts. The combination of antibiotic prophylaxis and bowel preparation has been used to prevent hepatic abscess. We describe our outcomes with moxifloxacin prophylaxis alone without bowel preparation. Ten patients underwent 25 procedures and were followed for a median of 250 days. No abscesses developed. Our results suggest moxifloxacin alone may suffice for prophylaxis.
Medical subject headings
- Anti-Infective Agents
- Antibiotic Prophylaxis
- Aza Compounds
- Embolization, Therapeutic
- Liver Abscess
- Liver Neoplasms
- Quinolines